Company intelligence / Profile preview
Nitto
- Ownership
- Public · 6988
- Employees
- ~28000
- Development stage
- Other
Overview
Nitto Denko Corporation, commonly known as Nitto, is a diversified Japanese materials manufacturer that has established a significant presence in the life sciences sector. The company operates as a leading Contract Development and Manufacturing Organization (CDMO) through its subsidiary Nitto Denko Avecia, specializing in oligonucleotide therapeutics. Nitto also engages in internal drug discovery via Nitto BioPharma, focusing on fibrosis and oncology using proprietary drug delivery systems. Their healthcare portfolio includes transdermal drug delivery patches, medical tapes, and advanced surgical materials. By leveraging its expertise in polymer chemistry, Nitto continues to innovate in the fields of nucleic acid medicine and minimally invasive medical devices.
- Therapeutic areas
- PulmonologyOncologyGastroenterology
- Modalities
- Small interfering RNAAntisense oligonucleotideSmall moleculeTransdermal patchLipid nanoparticle delivery therapy
- Industry
- Biotech
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Nitto.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nitto.